Home＜ News & Events

News & Events

News Events Media Attention Partner News

 

2023.08
14

Exploring the Dark Horse in the ADC CDMO Field：TOT Biopharm's (01875.HK) continuous performance growth attracted attention
2023.07
28

A Biotech decided to fully turn into CDMO
2023.03
27

What we can learn from the success of TOT BIOPHARM transformed into a CDMO company ?
2023.03
24

On a journey to recovery, TOT BIOPHARM-B (01875.HK) establishes core competitive advantages to capture the lead of the industry
2023.03
20

Revenue increased nearly fivefold and cash flows from operating activities turned positive, revealed TOT BIOPHARM-B (01875) achieved remarkable results in strategic transformation
2023.03
20

ADC enjoys a promising future! TOT BIOPHARM's differentiated CDMO strategy achieved initially, cash flow turns positive for the first time!
2022.12
26

CDMO transformation and upgrading proved effective, TOT BIOPHARM-B (1875.HK) embraces opportunities prospective strategic adjustment
2022.09
09

TOT BIOPHARM-B (1875.HK) releases quality growth potential steadily, cash flows from operating activities turned positive for the first time!
2022.08
31

ADC heat brings new opportunities, lack of professional CDMO supplier triggers capacity battle